Key result
Thrombolytic therapy for acute myocardial infarction significantly shortened high frequency QRS duration at 1 and 24 hours compared to presentation (96.8 and 93.4 vs 103.3 ms, P<0.05).
Why the study?
Does thrombolytic therapy alter signal-averaged ECG parameters (QRS duration, terminal voltage, late potentials) serially over 7-10 days in patients with acute myocardial infarction?
Observational (n=21)
Does thrombolytic therapy alter signal-averaged ECG parameters (QRS duration, terminal voltage, late potentials) serially over 7-10 days in patients with acute myocardial infarction?
Thrombolytic therapy in acute myocardial infarction leads to early, dynamic changes in signal-averaged ECG parameters, which may reflect ischemia and reperfusion rather than a fixed arrhythmogenic substrate.
SAECG changes after thrombolysis may indicate myocardial recovery; hypothesis-generating and should not yet change practice.
Signal averaging has been performed to evaluate late potentials following infarction and the administration of thrombolytic therapy. Most studies have recorded signal-averaged electrocardiograms (SAECGs) at least 12 hours after the onset of the infarction. In this study, SAECGs were recorded before thrombolytic therapy and serially over 7-10 days following infarction in 21 patients. The high frequency QRS duration was significantly shortened at 1 and 24 hours compared to presentation (96.8 +/- 11.3 ms and 93.4 +/- 8.0 ms vs 103.3 +/- 14.3 ms, respectively, P < 0.05) and there was an increase in the terminal voltage over time, significant at 1 hour and 3 days (57.3 +/- 29.1 microV and 58.6 +/- 44.7 microV vs 44.4 +/- 35.5 microV, respectively, P < 0.01). Five patients met criteria for ventricular late potentials on at least one SAECG. The prevalence of late potentials was higher in patients with Q wave infarctions, or with occluded infarct related arteries. These changes in myocardial activation may be related to ischemia and reperfusion, and may not correlate with the development of a fixed substrate for reentry.
No takes yet. Share an insight, caveat, or question.
Beauregard et al. (1996) conducted an observational in Acute Myocardial Infarction (n=21). Thrombolytic therapy vs. Baseline (presentation) was evaluated on High frequency QRS duration and terminal voltage (p=<0.05). Thrombolytic therapy for acute myocardial infarction significantly shortened high frequency QRS duration at 1 and 24 hours compared to presentation (96.8 and 93.4 vs 103.3 ms, P<0.05).
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: